Omkar Pharmachem Appoints New Independent Director, Sets Date for 30th AGM
Omkar Pharmachem Limited's board meeting on August 27, 2025, resulted in key decisions. The company's 30th AGM is scheduled for September 24, 2025, in Ahmedabad. Mr. Anupam Kumar Mishra, 55, was appointed as an Additional Non-executive Independent Director for a five-year term, subject to shareholder approval. The board also approved material related party transactions, appointed a scrutinizer for AGM voting, and approved the Director's report for FY 2024-25.
*this image is generated using AI for illustrative purposes only.
Omkar Pharmachem Limited , a pharmaceutical company based in Ahmedabad, has announced significant developments following its recent board meeting. The company has appointed a new independent director and set the date for its upcoming Annual General Meeting (AGM).
Board Meeting Outcomes
The Board of Directors of Omkar Pharmachem Limited convened on August 27, 2025, and approved several key items:
30th AGM Schedule: The company's 30th Annual General Meeting is scheduled for September 24, 2025, at 11:30 a.m. It will be held at Hotel Kanak, opposite Gujarat College, Ellisbridge, Ahmedabad.
New Independent Director: Mr. Anupam Kumar Mishra has been appointed as an Additional Non-executive Independent Director for a five-year term, effective August 27, 2025, subject to shareholder approval.
Material Related Party Transactions: The board approved material related party transactions, though specific details were not disclosed.
AGM Scrutinizer: M/s Maulik Bhavsar & Associates, a practicing company secretary firm, has been appointed as the scrutinizer for the AGM voting process for the financial year 2024-25.
Director's Report: The board approved the Director's report along with its annexures for the financial year ended March 31, 2025.
New Independent Director Profile
Mr. Anupam Kumar Mishra, aged 55, brings extensive experience in Management and Accountancy to Omkar Pharmachem's board. His appointment is based on the recommendation of the Nomination and Remuneration Committee and is subject to shareholder approval at the upcoming AGM.
Key details of Mr. Mishra's appointment include:
- Term: Five consecutive years, from August 27, 2025, to August 26, 2030
- Designation: Additional Director designated as Non-Executive Independent Director
- DIN: 03629083
The company has confirmed that Mr. Mishra has not been debarred from holding the office of a Director by any order passed by SEBI or any other such authority.
Additional Information
The board meeting commenced at 11:30 A.M. and concluded at 12:30 P.M. The company's management, led by Managing Director Bhawani Shankar Goyal, has submitted these details to the BSE Limited in compliance with SEBI regulations.
Omkar Pharmachem Limited continues to demonstrate its commitment to corporate governance through these appointments and disclosures. Shareholders and interested parties can look forward to more details at the upcoming AGM in September.
Historical Stock Returns for Omkar Pharmachem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | 0.0% | -14.40% | -4.68% | +35.16% |
17
